The effect of bevacizumab on colon anastomotic healing in rats
- PMID: 20689957
- DOI: 10.1007/s00384-010-1039-x
The effect of bevacizumab on colon anastomotic healing in rats
Abstract
Purpose: The aim of the study was to investigate the effect of angiogenesis inhibition by bevacizumab, a monoclonal anti-vascular endothelial growth factor (VEGF) antibody, on the healing process of colonic anastomoses in rats, assessing some specific involved factors. This new agent is used mainly in metastatic colorectal cancer. The angiogenesis plays an important role in both wound healing and metastatic invasion and spread of malignant cells. There has not been any evidence assessing the optimal time for its safe use in operated patients.
Materials and methods: Forty Wistar rats were randomly allocated into four equal groups. A colonic anastomosis was performed in all rats. Half of them received intraoperatively a single dose of bevacizumab 5 mg/body weight and the rest received placebo. The animals were sacrificed on the 7th (Avastin 7th, placebo 7th) and 14th (Avastin 14th, placebo 14th) postoperative day. The anastomosis was resected and sent for histological study and for tissue biochemical assays (VEGF, endothelin-1 (ET-1), C-reactive protein (CRP), pro-oxidant-antioxidant balance (PAB), carbonylated proteins, hydroxyproline) using specific enzyme-linked immunosorbent assay kits. For statistical analysis, the Mann-Whitney U test was used (of statistical significance when P < 0.05).
Results: No complication or anastomotic dehiscence was observed. Histology did not reveal statistically significant differences between groups concerning degree of inflammation, fibroblasts, collagen, and fibrosis. Likewise, hydroxyproline levels did not differ. However, some statistically significant differences were found in VEGF, CRP and carbonyl proteins (Avastin 7th vs placebo 7th, placebo 14th vs placebo 7th), ET-1, and PAB (Avastin 14th vs Avastin 7th), which did not finally affect the collagen synthesis marker hydroxyproline, nor did the anastomotic strength.
Conclusions: Bevacizumab, when administered intraoperatively, has no significant effect on colon anastomotic healing in rats despite a transient mild ischemia.
Similar articles
-
Intraperitoneal administration of bevacizumab intraoperatively does not affect abdominal wound healing in rats.Eur Surg Res. 2011;47(1):45-51. doi: 10.1159/000327970. Epub 2011 May 21. Eur Surg Res. 2011. PMID: 21606651
-
"Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.J Surg Oncol. 2008 Feb 1;97(2):180-5. doi: 10.1002/jso.20938. J Surg Oncol. 2008. PMID: 18095268
-
Effects of intraperitoneal bevacizumab administration on colonic anastomosis and early postoperative adhesion formation.Surg Innov. 2013 Dec;20(6):559-65. doi: 10.1177/1553350613480855. Epub 2013 Mar 13. Surg Innov. 2013. PMID: 23487032
-
Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.Dan Med J. 2012 Mar;59(3):B4420. Dan Med J. 2012. PMID: 22381097 Review.
-
Bevacizumab and wound-healing complications: mechanisms of action, clinical evidence, and management recommendations for the plastic surgeon.Ann Plast Surg. 2013 Oct;71(4):434-40. doi: 10.1097/SAP.0b013e31824e5e57. Ann Plast Surg. 2013. PMID: 22868316 Review.
Cited by
-
Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.J Cell Mol Med. 2013 Dec;17(12):1632-43. doi: 10.1111/jcmm.12151. Epub 2013 Oct 9. J Cell Mol Med. 2013. PMID: 24118824 Free PMC article.
-
Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.Clin Cancer Res. 2011 May 15;17(10):3282-92. doi: 10.1158/1078-0432.CCR-10-3203. Epub 2011 Mar 8. Clin Cancer Res. 2011. PMID: 21385926 Free PMC article.
-
The effect of antivascular endothelial growth factor on the development of adhesion formation in laparotomized rats: experimental study.Gastroenterol Res Pract. 2011;2011:578691. doi: 10.1155/2011/578691. Epub 2011 Jun 28. Gastroenterol Res Pract. 2011. PMID: 21760775 Free PMC article.
-
The Science of Anastomotic Healing.Semin Colon Rectal Surg. 2022 Jun;33(2):100879. doi: 10.1016/j.scrs.2022.100879. Epub 2022 Mar 8. Semin Colon Rectal Surg. 2022. PMID: 35937614 Free PMC article.
-
Bevacizumab-associated intestinal perforation and perioperative complications in patients receiving bevacizumab.Ann Gastroenterol Surg. 2020 Feb 12;4(2):151-155. doi: 10.1002/ags3.12312. eCollection 2020 Mar. Ann Gastroenterol Surg. 2020. PMID: 32258980 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous